Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Merck & Co’s Clesrovimab Has Beyfortus Hill To Climb In RSV
Oct 18 2024
•
By
Elizabeth Cairns
Beyfortus is approved for newborns and toddlers in their second RSV season • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from Therapy Areas